Research Article Summary on Electroconvulsive Therapy

Most individuals likely to seek ECT or to be recommended for the therapy are those also presenting resistance to pharmacological agents. It is ideal for patients with depressive episodes, severe mood, and psychotic disorders (Espinoza et al., 2022). The Li et al. (2020) article examined the effects of ECT on depression. The authors acknowledged depression being a common disorder associated with high mortality globally. This prevalent mood disorder causes many health providers to look into electroconvulsive therapy, which will entail electrical stimulation for a generalized seizure effect. This half-century-old technique is not without its potential challenges and concerns hence the usefulness of a study looking into its effects. First, the research article looked at the clinical studies of ECT as part of the literature review and revealed the therapy to be safe overall. Also, it had a high potential for clinical improvement when used in patients with the bitemporal option giving the best performance regarding ameliorating symptoms. In contrast, its use of bilateral electrodes still offers a more rapid response.

Buy this excellently written paper or order a fresh one from acemyhomework.com

ECT can combine with pharmacotherapy, and its results will likely be the same as when it does not accompany the additional therapy (Li et al., 2020). During combinations, the goal is to prevent adverse challenges while exposing patients to alternatives to adequately address the presented symptoms while working within available and approved mechanisms for their condition. Functional MRI studies show ECT to interact with the neuroplasticity aspects of the brain. The therapy is relatively safe for treating depression, especially for patients who seek remedies because they are treatment-resistance. In the reviewed studies, ECT results exceeded those of medication for treatment-resistant bipolar depression. They strengthened the argument for using this therapy to work with more persistent symptoms of depression, mainly if the correct doses are applied. The patients are unlikely to have significant cognitive decline, which is often a concern regarding the therapy. However, some patients had a cognitive decline, and the recovery from declination was put at a likelihood of six months. The exact link between memory loss and ECT in patients is unclear. The common side effects, including headache and nausea/vomiting, remain mild in severity and prevalence.

ECT therapy is most suitable for people experiencing increased resistance to other treatments ((Li et al., 2020). The bioinformatics available can help to determine the ideal patients, which according to the reviewed article, would be the unipolar depressed patients with psychotic symptoms. Also, the available evidence supports the likelihood of elderly patients reaching remission. When testing out the efficacy rates, most animal studies use ECS, a version of ECT, for this purpose, and they report successful education in depressive states or stresslinked performance. The therapy prevents depression or damage due to the condition. The authors also explain that the potential working of ECS would be the remodeling of neuroplasticity.

Overall, the research article confirmed the clinical utilization of ECT and its effectiveness and relative safety, which explains its continued usage for several decades. Applications for treatment mainly targeted treatment-resistant depressed patients, but new evidence shows a need to rely on continuation ECT rather than on-time ECT. The heterogeneity of patients still affects the ease of determining the exact role of ECT in some cognitive profiles reported during previous studies. Finally, access to ECT and its utilization remains low.

References

Espinoza, R. T., & Kellner, C. H. (2022). Electroconvulsive therapy. New England Journal of Medicine, 386(7), 667-672. https://doi.org/10.1111/acps.13134

Li, M., Yao, X., Sun, L., Zhao, L., Xu, W., Zhao, H., ... & Cui, R. (2020). Effects of electroconvulsive therapy on depression and its potential mechanism. Frontiers in Psychology, 11(80), 1–13. https://doi.org/10.3389/fpsyg.2020.00080